Who Paid My Doc
Vivacit-E
Device Hips
PDI 00889024572829
General payments
$813
Research payments
$157,554
Through program year 2025, $813 in general payments and $157,554 in research payments were reported against Vivacit-E (Hips).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $36,120 | 19 |
| 2024 | Research | $24,109 | 14 |
| 2023 | Research | $62,680 | 10 |
| 2022 | General | $813 | 3 |
| 2022 | Research | $34,645 | 12 |
Breakdown
Each share is of general payments naming this product in 2022.
Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2022 where a state was reported.
Records
3 general · 55 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.